Gary Schwartz, MD

Trials

Studies that name Gary Schwartz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:16 UTC. Open this list on ClinicalTrials.gov

• Ph4
  NCT04496362 · Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study

  Baylor Research Institute · active not recruiting · ECMO, Heparin, Respiratory Failure · principal investigator
• Ph1
  NCT02619669 · Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer

  Gary Schwartz · withdrawn · Breast Cancer · principal investigator
• N/A
  NCT02010021 · Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.

  Dartmouth-Hitchcock Medical Center · completed · Breast Cancer · principal investigator
• N/A
  NCT01750164 · Patient Derived Breast Cancer Xenografts

  Dartmouth-Hitchcock Medical Center · terminated · Metastatic Breast Cancer · principal investigator
• Ph1
  NCT00704821 · PTC299 for Treatment of Advanced Cancer

  PTC Therapeutics · terminated · Advanced Cancer · principal investigator
• Ph2
  NCT00522457 · Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy

  Neovii Biotech · terminated · Metastatic Breast Cancer, Advanced Breast Cancer · principal investigator
• Ph1/Ph2
  NCT00520299 · Study of ADI-PEG 20 in Patients With Advanced Melanoma

  Ludwig Institute for Cancer Research · completed · Metastatic Melanoma, Skin Cancer, Neoplasm · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.